NF-κB-regulated exosomal miR-155 promotes the inflammation associated with arsenite carcinogenesis

被引:89
作者
Chen, Chao [1 ,2 ]
Luo, Fei [1 ,2 ]
Liu, Xinlu [1 ,2 ]
Lu, Lu [1 ,2 ]
Xu, Hui [1 ,2 ]
Yang, Qianlei [1 ,2 ]
Xue, Junchao [1 ,2 ]
Shi, Le [1 ,2 ]
Li, Jun [3 ]
Zhang, Aihua [3 ]
Liu, Qizhan [1 ,2 ]
机构
[1] Nanjing Med Univ, Inst Toxicol, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing 211166, Jiangsu, Peoples R China
[3] Guiyang Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Pollut Monitoring & Dis Control, Guiyang 550025, Guizhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Arsenite; Exosomes; miRNA; Inflammation; INTERCELLULAR-COMMUNICATION; MESSENGER-RNA; STROMAL CELLS; CANCER-CELLS; MICROVESICLES; MICRORNAS; TRANSFORMATION; MACROPHAGES; PROLIFERATION; ANGIOGENESIS;
D O I
10.1016/j.canlet.2016.11.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the cancer microenvironment, extracellular communication allows various types of cells to coordinate and execute biological functions. Emerging evidence indicates that exosomes, as mediators of cell communication, are involved in tumor progression. Little is known, however, about the mechanism by which exosomal miRNAs regulate inflammatory infiltration in arsenite-induced liver cancer. The present research aimed to determine if miRNAs secreted from arsenite-transformed human hepatic epithelial (L-02) cells are transferred into normal L-02 and THLE-3 cells, which are functionally active in the recipient cells. The results show that the exosomes from arsenite-transformed L-02 cells enhance miR-155 expression and the pro-inflammatory properties of normal L-02 and THLE-3 cells. Transformed cells transfer miR-155 into normal L-02 cells via exosomes. The inhibition of NF-kappa B by siRNA and inhibitor, which reduces miR-155 levels in exosomes derived from transformed L-02 cells, blocks inflammation. Arsenite-transformed cells secrete exosomes to enhance inflammation, but the inhibition of the synthesis of exosomes fails to stimulate inflammation. miR-155 is involved in exosome-mediated intercellular communication between neoplastic and normal liver cells. In addition, miR-155, IL-6, and IL-8 were over-expressed in the serum of arsenite exposure group. And there was a positive correlation between miR-155 and IL-6 or IL-8 levels. Further, exosomal miR-155 was up-regulated in the serum of arsenite exposure group. Thus, these results show that exosomes derived from transformed L-02 cells transfer miR-155 to surrounding cells, which induces pro-inflammatory activity of normal liver cells. The findings support the concept that exosomal miRNAs are involved in cell cell communication during carcinogenesis induced by environmental chemicals. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:21 / 33
页数:13
相关论文
共 50 条
  • [41] Epithelial NF-κB activation promotes urethane-induced lung carcinogenesis
    Stathopoulos, Georgios T.
    Sherrill, Taylor P.
    Cheng, Dong-Sheng
    Scoggins, Robert M.
    Han, Wei
    Polosukhin, Vasiliy V.
    Connelly, Linda
    Yull, Fiona E.
    Fingleton, Barbara
    Blackwell, Timothy S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (47) : 18514 - 18519
  • [42] 4′,6-Dihydroxy-4-methoxyisoaurone inhibits TNF-α-induced NF-κB activation and expressions of NF-κB-regulated target gene products
    Ma, Juan
    Mi, Chunliu
    Wang, Ke Si
    Lee, Jung Joon
    Jin, Xuejun
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (02) : 43 - 50
  • [43] The preventative effect of Akt knockout on liver cancer through modulating NF-κB-regulated inflammation and Bad-related apoptosis signaling pathway
    Hu, Bin
    Sun, Ming
    Liu, Jiajun
    Hong, Guolin
    Lin, Qin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (04) : 1467 - 1476
  • [44] 1-Dehydro-[10]-gingerdione from ginger inhibits IKKβ activity for NF-κB activation and suppresses NF-κB-regulated expression of inflammatory genes
    Lee, Hwa Young
    Park, Sun Hong
    Lee, Misoon
    Kim, Hye-Jin
    Ryu, Shi Yong
    Kim, Nam Doo
    Hwang, Bang Yeon
    Hong, Jin Tae
    Han, Sang-Bae
    Kim, Youngsoo
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (01) : 128 - 140
  • [45] Liquid biopsy for CNS lymphoma: CSF exosomes and CSF exosomal miR-15a, miR-21, miR-155, miR-210, and miR-19b are promising biomarkers for diagnosis
    Hatiboglu, Mustafa Aziz
    Karacam, Busra
    Khan, Imran
    Akdur, Kerime
    Elbasan, Elif Burce
    Mahfooz, Sadaf
    Seyithanoglu, Mehmet Hakan
    Cetin, Guven
    Papaker, Meliha Gundag
    Oztanir, Mustafa Namik
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [46] Identification of DR5 as a critical, NF-κB-regulated mediator of Smac-induced apoptosis
    Eckhardt, I.
    Roesler, S.
    Fulda, S.
    CELL DEATH & DISEASE, 2013, 4 : e936 - e936
  • [47] Epithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment
    Saxon, Jamie A.
    Sherrill, Taylor P.
    Polosukhin, Vasiliy V.
    Sai, Jiqing
    Zaynagetdinov, Rinat
    McLoed, Allyson G.
    Gulleman, Peter M.
    Barham, Whitney
    Cheng, Dong-Sheng
    Hunt, Raphael P.
    Gleaves, Linda A.
    Richmond, Ann
    Young, Lisa R.
    Yull, Fiona E.
    Blackwell, Timothy S.
    ONCOIMMUNOLOGY, 2016, 5 (06):
  • [48] Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway
    Wu, Xue
    Liu, Ping
    Zhang, Haijun
    Li, Yuan
    Salmani, Jumah Masoud Mohammad
    Wang, Fei
    Yang, Ke
    Fu, Rong
    Chen, Zhewei
    Chen, Baoan
    BMC CANCER, 2017, 17
  • [49] Feedback loop in miR-449b-3p/ADAM17/NF-κB promotes metastasis in nasopharyngeal carcinoma
    Fei, Qian
    Du, Ming-Yu
    Qian, Lu-Xi
    Chen, Han-Bo
    Chen, Jie
    Zhu, Hong-Ming
    Tian, Xiao-Kang
    Jiang, Ning
    Gu, Jia-Jia
    He, Xia
    Yin, Li
    CANCER MEDICINE, 2019, 8 (13): : 6049 - 6063
  • [50] miR-489-3p inhibits TLR4/NF-κB signaling to prevent inflammation in psoriasis
    Ye, Yujian
    Wang, Ping
    Zhou, Fangmei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (01)